We’re always working hard to deliver the best outcomes for our entrepreneurs and investors, which is why we’re thrilled to be recognised as a finalist in two categories by Enterprise Investment Scheme Association (EISA) – Best EIS Investment Manager (sponsored by Protean Risk Limited ) and Best... Read more
Par Equity portfolio company Novosound has launched its range of non-destructive testing (NDT) products to revolutionise the NDT market across sectors including oil and gas, renewables, energy and aerospace.
We are proud to have supported Novosound and the team through the development... Read more
Par Portfolio Company, Current Health , has partnered with Dexcom to deliver continuous glucose monitoring through the Company's AI-powered remote patient monitoring platform. This partnership provides a great opportunity for health systems to obtain detailed insights into patient health,... Read more
Par Partner, Andrew Noble recently spoke to What Investment Magazine about the positive opportunities that have emerged as young, nimble technology businesses navigate the COVID-19 crisis and why the success of these exciting technology companies is good for both investors and the economy,... Read more
Par portfolio company, novosound has appointed Dr. Derek Mathieson, former Baker Hughes Senior Executive as chairman to drive the company's international growth strategy. Mathieson brings an outstanding history of commercial success and leadership to the team that will be vital to assisting the... Read more
Engineer Live highlights Par Portfolio Company, EC-OG, and its Halo Lithium-ion battery storage system providing novel subsea battery storage technology. The technology has recently passed the final stages of testing, marking a major milestone for its creator, an Aberdeen-based clean energy... Read more
We are excited to announce our continued support of Ronan Cunningham and the team at Belfast-based BrainWaveBank as they continue to scale their AI-based monitoring solution for Alzheimer’s and other neurological disorders.
We're delighted to announce our continued support for Publisher Discovery. The £800k investment round will support further development of the Company's affiliate marketing technology and expansion strategy. The new investment will be used to further develop the technology and to support... Read more
IFA Magazine recently highlighted Par Equity's Network Effect and the invaluable insight and critical thinking that our investor community brings to each stage of the investment cycle. The Par Investor Network contributes significantly to deal flow, due dilligance, portfolio management, and exit... Read more
We are excited to announce our continued support of Manus Neurodynamica as the company aims to revolutionise health care management through its Parkinson’s detecting technology. The funding from this round will be used to develop the Company's digital pen which provides an early warning of... Read more
UK Business Angels Association recently interviewed Par Equity Partner, Andrew Noble, on our new investment programme with the Regional Angel Programme, which aims to deploy £75m over the next 3 to 5 years. Andrew shares more on the programme, our investment approach and how portfolio... Read more
Par Portfolio company, Censo Biotechnologies, has risen to the COVID-19 testing challenge by offering free coronavirus tests to frontline workers. The company is also working with NHS Scotland to be able to augment their centralised testing programme.
We are very pleased to announce our continued support of UniKLasers in a £750,000 round of investment, supported by Scottish Enterprise. UniKLasers has achieved international sales and will use the funding to further expand the team and increase its manufacturing and R&D capacity. Read more
Fantastic initiative led by Edinburgh based Mallzee supports Bangladeshi workers affected by Coronavirus and reduces clothing waste. We are proud to back the team and their innovative solution making a difference on a global scale. Read more
As an early investor in Current Health (tagged), it’s great to see it go from strength to strength. This is an extremely challenging period for everyone and we’re particularly proud to back companies helping those on the front line.
Par Equity is delighted to announce the completion of a £1.6m investment round into EC-OG. This investment is the first through which we welcomed British Business Bank as our latest investment partner, the first of many co-investment deals to come.
Par Equity is thrilled to announce a £75m investment programme with British Business Investments, a commercial subsidiary of the British Business Bank. This £15m commitment from BBI will sit alongside Par’s EIS Fund and Investor Network to support some of the most exciting technology companies... Read more